RxDoctor Payments Data

Stacy Broussard, MD

Family Medicine · Saint Peters, MONPI 1932249356

Payments from drug & device makers

$7,549in general payments, 2019–2025

Across 460 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$998
  • Lilly USA, LLC$767
  • AstraZeneca$664
  • Amgen$641
  • Novo Nordisk$585
  • GSK$466
  • plus $3K from 44 others

What the payments were for

  • Food & beverage$7,541100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,549 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$71,350
Medicare patients
283
Services billed
700

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban104$110,235
JardianceEmpagliflozin81$93,928
OzempicSemaglutide52$56,390
FarxigaDapagliflozin Propanediol47$42,127
JanuviaSitagliptin Phosphate36$40,214
TrulicityDulaglutide18$35,843
XareltoRivaroxaban23$25,423
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$24,150
Breo ElliptaFluticasone/Vilanterol23$13,145
MounjaroTirzepatide14$13,015
AbrysvoRsv Vacc, Pref A And Pref B/Pf35$9,562
ArexvyRsvpref3 Antigen/As01e/Pf29$7,423
Atorvastatin Calcium713$6,164
BelsomraSuvorexant13$5,716
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,511

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$406$119,797139 claims
Boehringer IngelheimJardiance$401$93,92881 claims
Novo NordiskOzempic$585$56,39052 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Anoro Ellipta$466$50,22892 claims
Lilly USA, LLCTrulicity, Mounjaro$767$48,85832 claims
MerckJanuvia, Belsomra$211$45,93049 claims
AstraZenecaFarxiga$664$42,12747 claims
Johnson & JohnsonXarelto$18$25,42323 claims
AbbVieSynthroid$998$2,13930 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Peters

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →